Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

TP53 mutations predict for poor survival in ALK rearrangement lung adenocarcinoma patients treated with crizotinib

PaperCitations, authors & open-access status

TP53 mutations predict for poor survival in ALK rearrangement lung adenocarcinoma patients treated with crizotinib is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 69 citations, 2018 year and diamond oa status.

69
Citations
2018
Year
diamond
OA Status

Related on ScholarIQ

Wenxian Wang
Author
C. Xu
Author
Journal of Thoracic Disease
Journal
Lung Cancer Treatments and Mutations
Topic
Lung Cancer Treatments and Mutations
Topic
Cancer Genomics and Diagnostics
Topic
470M+ articles · free account